Showing results (451-460 of 504) with videos related to
Sort By:
Pageof 51
Communications Biology|November 20, 2025
A cross-sectional analysis of brain structure, pain behaviors, and mental health in persons with surgically confirmed endometriosisMaya L Jotwani, Edina Szabo, Gabriela Comptdaer, et al.Neuroimage|October 27, 2009
Improved characterization of BOLD responses for evoked sensory stimuliJaymin Upadhyay, Gautam Pendse, Julie Anderson, et al.BMJ Open|April 16, 2022
Development, evaluation and implementation of a digital behavioural health treatment for chronic pain: study protocol of the multiphase DAHLIA projectSara Laureen Bartels, Sophie I Johnsson, Katja Boersma, et al.JMIR Research Protocols|April 6, 2026
Targeted Real-Time Assessment of Chronic Pain (TRAC-Pain) in Youth: Protocol for a Digital Biosignature Development Through a Prospective Observational Cohort StudyAnna H Bailes, Chi-Hung Shu, Alan Chang, et al.The Clinical Journal of Pain|September 25, 2018
Contribution of Loss of Large Fiber Function to Pain in 2 Samples of Oncology PatientsChristine Miaskowski, Steven M Paul, Judy Mastick, et al.Journal of Personalized Medicine|December 24, 2025
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) AxisAlireza Sharafshah, Kenneth Blum, Kai-Uwe Lewandrowski, et al.The Clinical Journal of Pain|June 13, 2012
A day-hospital approach to treatment of pediatric complex regional pain syndrome: initial functional outcomesDeirdre E Logan, Elizabeth A Carpino, Gloria Chiang, et al.Canadian Journal of Pain = Revue Canadienne De La Douleur|January 10, 2022
Talking to Teens about Pain: A Modified Delphi Study of Adolescent Pain Science EducationHayley B Leake, Lauren C Heathcote, Laura E Simons, et al.Journal of the Neurological Sciences|September 9, 2022
Why haven't we solved the addiction crisis?Kenneth Blum, Abdalla Bowirrat, Luis Llanos Gomez, et al.Journal of Personalized Medicine|December 23, 2022
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent OpioidsMauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, et al.Pageof 51